Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Schedule of Revenue Recognition (Details)

v3.23.2
Revenue Recognition - Schedule of Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Total revenue $ 5,950 $ 5,200 $ 11,383 $ 10,231
Functional neurosurgery navigation and therapy        
Disaggregation of Revenue [Line Items]        
Total revenue 2,201 2,173 4,562 4,411
Functional Neurosurgery Navigation and Therapy - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 1,818 1,798 3,676 3,661
Functional Neurosurgery Navigation and Therapy - Services        
Disaggregation of Revenue [Line Items]        
Total revenue 383 375 886 750
Biologics and drug delivery        
Disaggregation of Revenue [Line Items]        
Total revenue 3,368 2,408 6,044 4,562
Biologics and Drug Delivery - Disposable Products        
Disaggregation of Revenue [Line Items]        
Total revenue 346 1,225 940 2,075
Biologics and Drug Delivery - Services and license fees        
Disaggregation of Revenue [Line Items]        
Total revenue 3,022 1,183 5,104 2,487
Capital equipment and software        
Disaggregation of Revenue [Line Items]        
Total revenue 381 619 777 1,258
Capital Equipment and Software - Systems and Software Products        
Disaggregation of Revenue [Line Items]        
Total revenue 173 434 351 884
Capital Equipment and Software - Services        
Disaggregation of Revenue [Line Items]        
Total revenue $ 208 $ 185 $ 426 $ 374